RSC Advances
Page 8 of 11
ARTICLE
DOI: 10.1039/C4RA12858C
6. To a solution of aldehyde 5 (200 mg, 0.626 mmol) in propionic acid was added 8ꢀhydroxyjulolidine (237 mg, 1.254 mmol, 2 eq) and
PTSA (11 mg, 0.062 mmol, 0.1 eq). The solution was protected from light and stirred at room temperature overnight. To the brown mixture
was added a solution of chloranil (152 mg, 0.626 mmol, 1 eq) in DCM (10 mL), the reaction turned dark and was allowed to stir overnight at
room temperature. The dark purple solution was concentrated to dryness, the residue was dissolved in DCM and purified by column
chromatography on silica gel (gradient of 100% DCM to 9/1 DCM/Methanol) to obtain 58 mg of 6 (∼13%) as a purple solid after
lyophilisation (dioxane/water : 1/1). 1HꢀNMR (300 MHz, CDCl3): δ 7.83 (d, J = 8.1 Hz, 2H, CH Ar PTSA counter ion), 7.05 (d, J = 8.0 Hz,
2H, CH Ar PTSA counter ion), 6.93 (t, J = 7.6 Hz, 5H, Ha, Hb, Hc, H3), 4.70 (d, J = 2.2 Hz, 2H, CH2O), 4.27 (s, 4H, NCH2), 3.83 (s, 6H, 2
OMe), 3.55 (m, 8H, H1, H4), 3.02 (t, J = 6.1 Hz, 4H, H6), 2.73 (t, J = 6.0 Hz, 4H, H3), 2.57 (t, J = 2.1 Hz, 1H, C≡CH), 2.27 (s, 3H, Me PTSA
counter ion), 2.12ꢀ1.98 (m, 8H, H5, H2). 13CꢀNMR (75 MHz, CDCl3): δ 171.73 (CO esters), 154.11 (C Ar), 152.22 (C Ar), 151.04 (C Ar),
148.20 (C Ar), 144.65 (C Ar), 141.08 (C Ar), 138.14 (C Ar), 128.15 (CH PTSA), 126.77 (C7), 126.29 (CH PTSA), 125.35, 124.10 (CH Ar),
123.56, 118.09 (CH Ar), 116.10 (CH Ar), 112.75, 105.43, 78.00 (C≡CH), 76.28 (C≡CH), 56.78 (CH2O), 53.87 (NCH2), 52.15 (2 OMe),
50.95 (C1 or C4), 50.48 (C1 or C4), 27.73 (C3), 21.29 (Me PTSA), 20.73 (C2), 19.96 (C6), 19.77 (C5). MS (ES+), calcd for C40H42N3O6 [M]+
660.3, found 660.7. HRMS (ES+), calcd for C40H42N3O6 [M]+ 660.3068, found 660.3079.
9 was obtained as a purple solid after lyophilisation with ∼20% yield. 1HꢀNMR (300 MHz, CDCl3): δ 8.11 (s, 1H, H triazol), 7.71 (d, J = 8.1
Hz, 2H, 2CH PTSA), 6.95 (dd, J = 4.8, 3.0 Hz, 3H, CH PTSA, 1CH Ar), 6.86ꢀ6.73 (m, 4H, CH Ar), 5.22 (s, 2H, CH2COOMe), 5.11 (s, 2H,
OCH2), 4.16 (s, 4H, NCH2), 3.68 (s, 3H, OMe), 3.65 (s, 6H, 2 OMe), 3.44 (m, 8H, H1, H4), 2.94 (t, J = 6.1 Hz, 4H, H6), 2.69ꢀ2.64 (m, 4H,
H3), 2.18 (s, 3H, Me PTSA), 2.02 (t, J = 5.1 Hz, 4H, H5), 1.93ꢀ1.91 (m, 4H, H2). 13CꢀNMR (75 MHz, CDCl3): δ 171.82 (CO esters), 166.99
(CO ester), 154.70 (C Ar), 152.26 (C Ar), 151.02 (C Ar), 149.12 (C Ar), 144.59 (C Ar), 142.88 (C Ar), 141.13 (C Ar), 138.21 (C Ar), 128.18
(CH PTSA), 127.03 (C7), 126.23 (CH PTSA), 126.09 (CH triazol), 125.36(C Ar), 123.63 (C Ar), 123.48 (CH Ar), 117.91 (CH Ar), 115.93
(CH Ar), 112.88 (C Ar), 105.24 (C Ar), 62.56 (OCH2), 53.82 (NCH2), 52.92 (OMe), 52.03 (2 OMe), 50.96 (C1 or C4), 50.79 (CH2COOMe),
50.44 (C1 or C4), 27.64 (C3), 21.28 (Me PTSA), 20.74 (C2), 19.97(C6), 19.81 (C5). MS (ES+), calcd for C43H47N6O8 [M]+ 775.3, found 776.0.
HRMS (ES+), calcd for C43H47N6O8 [M]+ 775.3450, found 775.3473.
12 was obtained as a purple solid after lyophilisation with ∼16% yield. 1HꢀNMR (300 MHz, CDCl3): δ 7.73 (d, J = 7.9 Hz, 2H, CH PTSA),
7.71 (H triazol) 7.02ꢀ6.83 (m, 7H, 2CH PTSA, Ha, Hb, Hc, 2H7), 5.45 (s, 2H, CH2COOMe), 5.33 (s, 2H, OCH2), 4.21 (s, 4H, NCH2), 3.72 (s,
3H, OMe), 3.70 (s, 6H, 2 OMe), 3.57ꢀ3.51 (m, 8H, H1, H4), 3.02 (t, J = 6.1 Hz, 4H, H6), 2.77ꢀ2.71 (m, 4H, H3), 2.26 (s, 3H, Me PTSA), 2.13ꢀ
2.08 (m, 4H, H5), 2.02ꢀ2.00 (m, 4H, H2). 13CꢀNMR (75 MHz, CDCl3): δ 171.55 (CO esters), 167.27 (CO ester), 154.00 (C Ar), 152.21 (C
Ar), 151.07 (C Ar), 148.62 (C Ar), 144.52 (C Ar), 141.05 (C Ar), 138.23 (C Ar), 134.55 (CH triazol), 133.20 (C Ar), 128.16 (CH PTSA),
126.73 (C7), 126.16 (CH PTSA), 126.05 (C Ar), 124.12 (CH Ar), 123.77 (C Ar), 118.76 (CH Ar), 116.13 (CH Ar), 112.84 (C Ar), 105.30 (C
Ar), 59.91 (OCH2), 53.51 (NCH2), 52.94 (OMe), 52.04 (2 OMe), 50.99 (C1 or C4), 50.47 (C1 or C4), 49.72 (CH2COOMe), 27.64 (C3), 21.29
(Me PTSA), 20.71 (C2), 19.96 (C6), 19.79 (C2). MS (ES+), calcd for C43H47N6O8 [M]+ 775.3450, found 775.7. HRMS (ES+), calcd for
C43H47N6O8 [M]+ 775.3450, found 775.3495.
4.4 Saponification : typical procedure
13. To a solution of 12 (90 mg, ∼0.10 mmol) in methanol (10 mL) were added 700 mg of KOH and water (3 mL), the mixture was stirred
overnight. The product was washed with aq HCl (1M) and extracted with CHCl3 until the aqueous phase become slightly pink. The organic
phase was then dried over MgSO4, filtered and concentrated. The residue was purified on a reverse phase column Cꢀ18 using acetonitrile
(0.1% TFA) and water (0.1% TFA) as eluant (20% ACN to 60%), monitored at 254 nm. The solvents were evaporated and 64 mg of 13
(76%) were obtained as a purple solid after lyophilisation (dioxane/water, 1/1). HRMS (ES+), calcd for C40H41N6O8 [M]+ 733.2980, found
733.3002.
7 was obtained as a purple solid after lyophilisation with ∼74% yield. HRMS (ES+), calcd for C38H38N3O6 [M]+ 632.2755, found 632.2761.
10 was obtained as a purple solid after lyophilisation with ∼81% yield. HRMS (ES+), calcd for C40H41N6O8 [M]+ 733.2980, found 733.3002
4.5 Dextran Conjugates
Dextran 6,000 MW (SigmaꢀAldrich, ref: 31388) and dextran 1,500 MW (SigmaꢀAldrich, ref: 31394) were functionnalised with 1429 (see SI)
using a method described by Nielsen et al.30 The 1HꢀNMR showed that the functionnalised dextrans were alkylated once per glucose unit.
8 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 2012